$KNW
KNOW LABS, INC. Stock $knw

$knw Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000165495422011201 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue		$0.00	$8.687K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$1.589M	$1.448M
YoY Change		59.81%	7.86%
% of Gross Profit
Research & Development		$1.273M	$1.249M
YoY Change		46.51%	-0.79%
% of Gross Profit
Depreciation & Amortization		$100.6K	$76.40K
YoY Change		54.83%	18.21%
% of Gross Profit
Operating Expenses		$3.025M	$2.851M
YoY Change		62.41%	9.61%
Operating Profit		-$3.025M	-$2.843M
YoY Change		62.41%	9.28%
Interest Expense		$239.8K	$3.298M
YoY Change		-95.41%	18.96%
% of Operating Profit
Other Income/Expense, Net		$22.17K	$3.298M
YoY Change		-100.42%	18.96%
Pretax Income		-$3.003M	-$6.141M
YoY Change		-57.65%	14.28%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings		-$3.003M	-$6.141M
YoY Change		-57.65%	14.28%
Net Earnings / Revenue			-70688.82%
Basic Earnings Per Share
Diluted Earnings Per Share		-$68.63K	-$162.1K
COMMON SHARES
Basic Shares Outstanding	43.85M shares	43.75M shares	36.06M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$8.352M	$11.19M
YoY Change		-39.78%	-28.73%
Cash & Equivalents	$12.59M	$8.352M	$11.19M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$46.15K	$119.2K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$12.59M	$8.398M	$11.31M
YoY Change	2.74%	-39.45%	-27.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$863.0K	$953.4K	$1.037M
YoY Change	162.7%	757.02%	466.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$13.77K	$13.77K
YoY Change		0.0%	0.0%
Total Long-Term Assets	$1.165M	$1.229M	$1.357M
YoY Change	84.5%	690.14%	542.16%
TOTAL ASSETS
Total Short-Term Assets	$12.59M	$8.398M	$11.31M
Total Long-Term Assets	$1.165M	$1.229M	$1.357M
Total Assets	$13.76M	$9.627M	$12.66M
YoY Change	6.74%	-31.36%	-20.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$405.4K	$411.9K
YoY Change		0.12%	-5.23%
Accrued Expenses	$462.9K	$534.0K	$265.9K
YoY Change	-48.17%	-8.84%	-81.54%
Deferred Revenue
YoY Change
Short-Term Debt		$2.255M	$2.255M
YoY Change		-54.96%	-55.41%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.809M	$4.611M	$5.363M
YoY Change	-65.49%	-41.04%	-33.48%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$431.8K
YoY Change		-100.0%	0.0%
Other Long-Term Liabilities		$97.26K	$138.6K
YoY Change			53219.23%
Total Long-Term Liabilities	$87.12K	$97.26K	$570.4K
YoY Change	-85.72%	-52.7%	32.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.809M	$4.611M	$5.363M
Total Long-Term Liabilities	$87.12K	$97.26K	$570.4K
Total Liabilities	$3.896M	$4.708M	$5.934M
YoY Change	-66.55%	-41.34%	-30.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$101.4M	-$95.83M	-$92.82M
YoY Change	24.68%	29.97%
Common Stock	$48.16K	$43.80K	$43.74K
YoY Change	36.94%	29.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.863M	$4.919M	$6.729M
YoY Change
Total Liabilities & Shareholders Equity	$13.76M	$9.627M	$12.66M
YoY Change	6.74%	-31.36%	-20.4%

Cashflow Statement

Concept	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$3.003M	-$6.141M
YoY Change	-57.65%	14.28%
Depreciation, Depletion And Amortization	$100.6K	$76.40K
YoY Change	54.83%	18.21%
Cash From Operating Activities	-$2.669M	$885.8K
YoY Change	40.7%	-148.5%
INVESTING ACTIVITIES
Capital Expenditures	-$16.60K	-$441.5K
YoY Change	31.96%	1642.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$16.60K	-$441.5K
YoY Change	31.96%	1642.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-149.3K	9.000K
YoY Change	-279.1%	-99.94%
NET CHANGE
Cash From Operating Activities	-2.669M	885.8K
Cash From Investing Activities	-16.60K	-441.5K
Cash From Financing Activities	-149.3K	9.000K
Net Change In Cash	-2.835M	453.3K
YoY Change	55.23%	-96.45%
FREE CASH FLOW
Cash From Operating Activities	-$2.669M	$885.8K
Capital Expenditures	-$16.60K	-$441.5K
Free Cash Flow	-$2.653M	$1.327M
YoY Change	40.76%	-173.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001074828
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43802147	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35166551	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33719669	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2022Q1	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2027-01-05
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2801719	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	20000	shares
CY2022Q1	knwn	Shrare Issued Warrant To Purchased Price ShrareIssuedWarrantToPurchasedPrice	1.70
	dei	Local Phone Number LocalPhoneNumber	-903-1351
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-30262
	dei	Entity Registrant Name EntityRegistrantName	KNOW LABS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0273142
	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Union Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 810
	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98101
	dei	City Area Code CityAreaCode	206
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43849281	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8351945	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12258218	usd
CY2022Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	46146	usd
CY2021Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	0	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	8398091	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	12258218	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	953378	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328504	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	13767	usd
CY2021Q3	us-gaap	Other Assets OtherAssets	13767	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	262242	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	289002	usd
CY2022Q2	us-gaap	Assets Assets	9627478	usd
CY2021Q3	us-gaap	Assets Assets	12889491	usd
CY2022Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	405423	usd
CY2021Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	419093	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	533993	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	893137	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1270652	usd
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	421599	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2255066	usd
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	9191155	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	145815	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112371	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4610949	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11037355	usd
CY2022Q2	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	0	usd
CY2021Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	431803	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97261	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178170	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	97261	usd
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	609973	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43802147	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35166551	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	43803	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	35168	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100699797	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	82530684	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-95827137	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81326494	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4919268	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1242163	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9627478	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12889491	usd
CY2022Q2	us-gaap	Revenues Revenues	0	usd
CY2021Q2	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	4360087	usd
	us-gaap	Revenues Revenues	0	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1272537	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	868584	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3406996	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3094123	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1588823	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	994221	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4253997	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4934085	usd
CY2022Q2	us-gaap	Selling Expense SellingExpense	164093	usd
CY2021Q2	us-gaap	Selling Expense SellingExpense	0	usd
	us-gaap	Selling Expense SellingExpense	3436955	usd
	us-gaap	Selling Expense SellingExpense	0	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3025453	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1862805	usd
	us-gaap	Operating Expenses OperatingExpenses	11097948	usd
	us-gaap	Operating Expenses OperatingExpenses	8028208	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3025453	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1862805	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6737861	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8028208	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	239760	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	5228058	usd
	us-gaap	Interest Expense InterestExpense	8024709	usd
	us-gaap	Interest Expense InterestExpense	9735604	usd
CY2022Q2	us-gaap	Other Income OtherIncome	261927	usd
CY2021Q2	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	261927	usd
	us-gaap	Other Income OtherIncome	0	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	22167	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5228058	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7762782	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9735604	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3003286	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7090863	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-14500643	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17763812	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3003286	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-7090863	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14500643	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17763812	usd
CY2022Q2	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.07
CY2021Q2	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.23
	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.37
	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.64
CY2022Q2	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	43760904	shares
CY2021Q2	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	31052229	shares
	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	39032860	shares
	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	27651679	shares
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-1914911	usd
CY2020Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	175442	usd
CY2020Q4	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	561600	usd
CY2020Q4	knwn	Issuance Of Warrant For Services To Related Party IssuanceOfWarrantForServicesToRelatedParty	1811691	usd
CY2020Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	4688	usd
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-5299331	usd
CY2021Q1	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	127407	usd
CY2021Q1	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	210606	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	9769683	usd
CY2021Q1	knwn	Issuance Of Warrants To Debt Holders Note7 IssuanceOfWarrantsToDebtHoldersNote7	4439317	usd
CY2021Q1	knwn	Issuance Of Warrants For Services Related To Debt Offering IssuanceOfWarrantsForServicesRelatedToDebtOffering	1667281	usd
CY2021Q1	knwn	Issuance Of Common Stock For Services Amount IssuanceOfCommonStockForServicesAmount	202820	usd
CY2021Q1	knwn	Issuance Of Warrant For Services To Related Party IssuanceOfWarrantForServicesToRelatedParty	382566	usd
CY2021Q1	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	648516	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5373618	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	7413756	usd
CY2021Q2	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	267665	usd
CY2021Q2	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	5325853	usd
CY2021Q2	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	60000	usd
CY2021Q2	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	23344	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-7090863	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5999754	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1242163	usd
CY2021Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	204170	usd
CY2021Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	766486	usd
CY2021Q4	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	2344	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-5356619	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3141456	usd
CY2022Q1	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	432481	usd
CY2022Q1	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	15345720	usd
CY2022Q1	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	9000	usd
CY2022Q1	knwn	Issuance Of Common Stock For Services Amount IssuanceOfCommonStockForServicesAmount	153000	usd
CY2022Q1	knwn	Issuance Of Warrant For Services To Related Party IssuanceOfWarrantForServicesToRelatedParty	71220	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6140738	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	6729227	usd
CY2022Q2	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	919224	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13870183	usd
CY2022Q2	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	27500	usd
CY2022Q2	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	2343	usd
CY2022Q2	knwn	Modification Of Warrant Interest Expense ModificationOfWarrantInterestExpense	244260	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3003286	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14500643	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17763812	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	218683	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	166094	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	153000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	202820	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	71220	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2194257	usd
	knwn	Modification Of Warrant Interest Expense ModificationOfWarrantInterestExpense	244260	usd
	knwn	Modification Of Warrant Interest Expense ModificationOfWarrantInterestExpense	0	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1555875	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	570514	usd
	knwn	Right Of Use Net RightOfUseNet	-20705	usd
	knwn	Right Of Use Net RightOfUseNet	-1853	usd
	knwn	Gain On Forgiveness Of Notes Payable Ppp Loans GainOnForgivenessOfNotesPayablePppLoans	252700	usd
	knwn	Gain On Forgiveness Of Notes Payable Ppp Loans GainOnForgivenessOfNotesPayablePppLoans	0	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7272911	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9071592	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	46146	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-11413	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1612959	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	404469	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3691286	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5144506	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	843557	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	47553	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-843557	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-47553	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	14209000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	727117	usd
	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	0	usd
	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	340000	usd
	knwn	Proceeds From Note Payableppp ProceedsFromNotePayableppp	0	usd
	knwn	Proceeds From Note Payableppp ProceedsFromNotePayableppp	205633	usd
	knwn	Settlement Of Notes Payable Ppp Loans SettlementOfNotesPayablePppLoans	179103	usd
	knwn	Settlement Of Notes Payable Ppp Loans SettlementOfNotesPayablePppLoans	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13687	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23344	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	793986	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	713203	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	628570	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14764063	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3906273	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	9572004	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12258218	usd
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298179	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8351945	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	0	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	9769683	usd
	knwn	Issuance Of Warrants To Debt Holders IssuanceOfWarrantsToDebtHolders	0	usd
	knwn	Issuance Of Warrants To Debt Holders IssuanceOfWarrantsToDebtHolders	4439317	usd
	knwn	Issuance Of Warrants For Services Related To Debt Offering IssuanceOfWarrantsForServicesRelatedToDebtOffering	0	usd
	knwn	Issuance Of Warrants For Services Related To Debt Offering IssuanceOfWarrantsForServicesRelatedToDebtOffering	1667281	usd
	knwn	Cashless Warrant Exercise CashlessWarrantExercise	0	usd
	knwn	Cashless Warrant Exercise CashlessWarrantExercise	493601	usd
	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	14209000	usd
	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	5638275	usd
	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	1136720	usd
	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	460185	usd
CY2022Q2	knwn	Authorized Shares Of Capital Common Stock AuthorizedSharesOfCapitalCommonStock	205000000	shares
CY2021Q3	knwn	Authorized Shares Of Capital Common Stock AuthorizedSharesOfCapitalCommonStock	200000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	knwn	Authorized Common Stock Increased AuthorizedCommonStockIncreased	200000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Proceeds From Sale Of Other Assets1 ProceedsFromSaleOfOtherAssets1	4360087	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8351945	usd
CY2022Q2	knwn	Net Working Capital NetWorkingCapital	6042208	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-95827137	usd
	knwn	Proceeds Of Warrants Currently Outstanding ProceedsOfWarrantsCurrentlyOutstanding	16383908	usd
CY2022Q2	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	usd
	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Revenue Recognition </strong>- The Company determines revenue recognition from contracts with customers through the following steps:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the contract, or contracts, with the customer;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the performance obligations in the contract;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">determination of the transaction price;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">allocation of the transaction price to the performance obligations in the contract; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">recognition of the revenue when, or as, the Company satisfies a performance obligation.</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. During the nine months ended June 30, 2022, the Company’s artificial intelligence (AI) Deep Learning Platform began generating revenue from digital asset sales of NFT’s. The Company engineering team, using its research date, AI and proprietary algorithms, produced NFT’s in the form of digital art. The NFT’s produced had no recorded cost basis. </p>
	knwn	Earns Royalty EarnsRoyalty	0.10	pure
CY2022Q2	knwn	Total Amount Of Digital Asset Conversion Losses TotalAmountOfDigitalAssetConversionLosses	164093	usd
	knwn	Total Amount Of Digital Asset Conversion Losses TotalAmountOfDigitalAssetConversionLosses	3436955	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3406996	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3969972	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2033726	usd
	us-gaap	Advertising Expense AdvertisingExpense	514401	usd
	us-gaap	Advertising Expense AdvertisingExpense	240000	usd
CY2022Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	6041016	usd
CY2021Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	12217714	usd
	us-gaap	Derivatives Methods Of Accounting Hedge Effectiveness DerivativesMethodsOfAccountingHedgeEffectiveness	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Derivative Financial Instruments –</strong>Pursuant to ASC 815 “Derivatives and Hedging”, the Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company then determines if embedded derivative must be bifurcated and separately accounted for. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined that the conversion features for purposes of bifurcation within convertible notes payable were immaterial and there was no derivative liability to be recorded as of June 30, 2022 and September 30, 2021.</p>
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43802147	shares
CY2022Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	2255066	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33719669	shares
	knwn	Additional Common Shares Reserved AdditionalCommonSharesReserved	16124764	shares
CY2021Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	16464066	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Use of Estimates</strong> – The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
	knwn	Artificial Intelligence Ai Deep Learning Platform ArtificialIntelligenceAiDeepLearningPlatform	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>4. Artificial Intelligence (AI) Deep Learning Platform</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>AI Revenue</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the nine months ended June 30, 2022,<strong> </strong>the<strong> </strong>Company’s artificial intelligence (AI) Deep Learning Platform began generating revenue from digital asset sales of NFT’s and had sales of $4,360,087. The Company’s sales of NFT’s are generated using the NFT digital exchange, OpenSea. Customers purchasing the NFT’s must make payments in the crypto currency, Ethereum. The Ethereum is received into a digital wallet and then moved to an account at Coinbase where the Ethereum is converted to U.S. dollars. During the three months ended December 31, 2021, the Company was not able to establish a digital wallet and corporate account at Coinbase in order to receive the Ethereum. The Company used the digital wallet and Coinbase account of the Company’s CEO. The Company and the CEO executed an assignment of his account to the Company while the Company establishes its own Coinbase account. All proceeds received from the sale of NFT were deposited in the CEO’s personal digital accounts. As of December 31, 2021 the Company had recorded an accounts receivable-related party of $3,124,581 for the cash it expected to receive from the CEO’s personal digital account.</p>The Company has established a digital wallet and corporate account at Circle in order to receive the Ethereum and then convert it to cash. During 2022, the Company received $2,908,551 of Ethereum which was converted to cash and recorded a reduction in value of $169,884 related to the decline in value of the Ethereum. The accounts receivable-related party was $46,146 as of June 30, 2022. As of June 30, 2022, accrued expenses include $436,378 of expenses, primarily sales and use tax and other expenses. As of June 30, 2022 accrued expenses-related party include $799,353 of unpaid compensation that was due and payable to the CEO for the NFT revenue. This unpaid compensation was paid in July 2022. During 2021, approximately $1.3 million of the selling and transactional costs for the digital assets was paid through the CEO’s personal digital asset account including approximately $1.075 million which was paid to a consultant via the transfer of Ethereum.
CY2021Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	3124581	usd
	knwn	Sales And Use Tax SalesAndUseTax	436378	usd
CY2022Q2	knwn	Accrued Expenses AccruedExpenses	799353	usd
	knwn	Selling And Transactional Costs SellingAndTransactionalCosts	1300000	usd
	knwn	Amount Paid To Consultant AmountPaidToConsultant	1075000.000	usd
CY2022Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1498355	usd
CY2021Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	654798	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	usd
CY2021Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	usd
CY2022Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	usd
CY2021Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	575444	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	356761	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	953378	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328504	usd
	us-gaap	Depreciation Depreciation	218683	usd
	us-gaap	Depreciation Depreciation	64980	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	262242	usd
CY2022Q2	knwn	Operating Lease Liabilities For Remaining Long Term Lease OperatingLeaseLiabilitiesForRemainingLongTermLease	243076	usd
CY2021Q3	knwn	Operating Lease Liabilities For Remaining Long Term Lease OperatingLeaseLiabilitiesForRemainingLongTermLease	290000	usd
	us-gaap	Lease Cost LeaseCost	130767	usd
	us-gaap	Lease Cost LeaseCost	102741	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	159112	usd
	knwn	Finance Leases Weighted Average Remaining Lease Term FinanceLeasesWeightedAverageRemainingLeaseTerm	P20Y
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	156253	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	118602	usd
CY2022Q2	knwn	Total Remaining Payments TotalRemainingPayments	274855	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12629	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	262226	usd
CY2022Q2	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-14209000	usd
CY2021Q3	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-5639500	usd
CY2022Q2	knwn	Debt Discount Beneficial Conversion Feature DebtDiscountBeneficialConversionFeature	0	usd
CY2021Q3	knwn	Debt Discount Beneficial Conversion Feature DebtDiscountBeneficialConversionFeature	-4308337	usd
CY2022Q2	knwn	Debt Discount Warrants DebtDiscountWarrants	0	usd
CY2021Q3	knwn	Debt Discount Warrants DebtDiscountWarrants	-1957590	usd
CY2022Q2	knwn	Debt Discount Warrants Issued For Services DebtDiscountWarrantsIssuedForServices	0	usd
CY2021Q3	knwn	Debt Discount Warrants Issued For Services DebtDiscountWarrantsIssuedForServices	-1056984	usd
CY2022Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2255066	usd
CY2021Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	9191155	usd
	knwn	Gain On Loan Forgiveness GainOnLoanForgiveness	253000	usd
CY2022Q2	knwn	Common Stock Shares Issued1 CommonStockSharesIssued1	43826781	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2801719	shares
CY2022Q2	knwn	Options To Purchase Common Stock Share OptionsToPurchaseCommonStockShare	20927370	shares
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned	11550745	shares
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	21651513	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2255066	usd
CY2022Q2	knwn	Certaina Outstanding Warrants To Purchase CertainaOutstandingWarrantsToPurchase	10284381	shares
	knwn	Description Of Automatic Conversion Of Convertible DescriptionOfAutomaticConversionOfConvertible	The Company issued 7,672,860 shares of common stock related to the automatic conversion of Convertible Notes and interest from a private placement to accredited investors in 2021. The Convertible Notes and interested were automatically converted to Common Stock at $2.00 per share on the one year anniversary in March 2022
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.998
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	60000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	863986	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.919
	knwn	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	108756	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	21651513	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.003
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	21651513	shares
CY2022Q2	knwn	Warrant Issued To Common Stock WarrantIssuedToCommonStock	21651513	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	31557563	usd
CY2022Q2	knwn	Share Issued ShareIssued	8750	shares
CY2022Q2	knwn	Grant Received GrantReceived	13688	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1555875	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	570514	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7065596	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y1M24D
CY2019Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	2.025
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9180369	usd
CY2020	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	1.142
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	3522400	usd
CY2020	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	0.250
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	18298	usd
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.593
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	-7103921	usd
CY2020Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	1.161
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5580550	usd
CY2021	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	1.766
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	18807990	usd
CY2021	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	1.359
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	28031	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.300
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	-396000	usd
CY2021Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	1.565
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23964509	usd
	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	1.805
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	11632130	usd
	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	1.564
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13688	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.838
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	-1516150	usd
CY2022Q2	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	1.628
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	34066802	usd
CY2022Q2	knwn	Cash Received CashReceived	29085510000	usd
CY2022Q2	knwn	Reduction In Value ReductionInValue	1698840000	usd
CY2017Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	3334	usd
CY2017Q2	knwn	Lease Description LeaseDescription	lease expires on May 31, 2022
CY2021Q4	knwn	Lease Description LeaseDescription	we extended the lease from June 1, 2022 to May 31, 2023 at $2,986 per month
CY2019Q1	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	8697	usd
CY2019Q1	knwn	Lease Description LeaseDescription	The lease expires on June 30, 2024
CY2021Q4	knwn	Lease Description LeaseDescription	the Company entered into First Amendment of Lease and added 1,030 square feet for year for $5,000 per month. The space will be utilized for clinical trials
CY2022Q2	knwn	Segment Revenues SegmentRevenues	0	usd
CY2022Q2	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-3025000	usd
CY2022Q2	knwn	Segment Assets SegmentAssets	9627000	usd
CY2021Q2	knwn	Segment Revenues SegmentRevenues	0	usd
CY2021Q2	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-1863000	usd
CY2021Q2	knwn	Segment Assets SegmentAssets	14026000	usd
	knwn	Segment Revenues SegmentRevenues	4360000	usd
	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-6738000	usd
	knwn	Segment Revenues SegmentRevenues	0	usd
	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-8028000	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	9242544	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	12203424	usd
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	150000	shares
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.24
CY2022Q3	knwn	Fair Value Assumption Expected Term FairValueAssumptionExpectedTerm	five years
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4919268	usd

Files In Submission

Name	View Source	Status
0001654954-22-011201-index-headers.html	Edgar Link	pending
0001654954-22-011201-index.html	Edgar Link	pending
0001654954-22-011201.txt	Edgar Link	pending
0001654954-22-011201-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
knwn-20220630.xsd	Edgar Link	pending
knwn_10q.htm	Edgar Link	pending
knwn_10qimg17.jpg	Edgar Link	pending
knwn_ex1027.htm	Edgar Link	pending
knwn_ex311.htm	Edgar Link	pending
knwn_ex312.htm	Edgar Link	pending
knwn_ex321.htm	Edgar Link	pending
knwn_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
knwn-20220630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
knwn-20220630_pre.xml	Edgar Link	unprocessable
knwn-20220630_def.xml	Edgar Link	unprocessable
knwn-20220630_lab.xml	Edgar Link	unprocessable
knwn_10q_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KNW
KNOW LABS, INC. Stock $knw

2022 Q3 Form 10-Q Financial Statement

#000165495422011201 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW KNOW LABS, INC. Stock $knw

2022 Q3 Form 10-Q Financial Statement

#000165495422011201 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW
KNOW LABS, INC. Stock $knw